Press Releases

Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program

Multiple blocking antibodies discovered for Compugen novel immune checkpoint target candidate for treatment of cancer

Feb 29, 2016
MORE EVENTS
Banner